Live News Reader

Some of the articles presented on this website are accessed through RSS feeds from third-party sources that are not necessarily part of the Histiocytosis Association. While we try to select appropriate feeds to prevent objectionable content from being displayed, the presence of any article does not indicate endorsement or recommendation by the Histiocytosis Association.

If you know of a histio-related article that isn't shown here, please send the article to outreach@histio.org.

"Erdheim-Chester disease" - Google News
Erdheim Chester Disease Treatment Market 2025 | Where Will The Trends Go Next? - Skyline Gazette
Erdheim Chester Disease Treatment Market 2025 | Where Will The Trends Go Next?  Skyline Gazette
Monday, March 30, 2020 12:27:00 AM

2020-2026 Erdheim Chester Disease Treatment Global Market By Bausch Health, Cadila Healthcare, SANIS, Roche, Cardinal Health, Pfizer, Novartis - Galus Australis
2020-2026 Erdheim Chester Disease Treatment Global Market By Bausch Health, Cadila Healthcare, SANIS, Roche, Cardinal Health, Pfizer, Novartis  Galus Australis
Friday, March 6, 2020 3:00:00 AM

UAB joins the Erdheim-Chester Disease Care Center Network - UAB News
UAB joins the Erdheim-Chester Disease Care Center Network  UAB News
Tuesday, February 25, 2020 3:00:00 AM

Man publishes book on fighting through terminal disease - The New Lenox Patriot
Man publishes book on fighting through terminal disease  The New Lenox Patriot
Tuesday, March 17, 2020 3:00:00 AM

FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer - FDA.gov
FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer  FDA.gov
Monday, November 6, 2017 3:00:00 AM

Largest Study of Its Kind Reveals New Targetable Genetic Causes of the Rare Blood Disorder Histiocytosis - On Cancer - Memorial Sloan Kettering
Largest Study of Its Kind Reveals New Targetable Genetic Causes of the Rare Blood Disorder Histiocytosis  On Cancer - Memorial Sloan Kettering
Wednesday, December 4, 2019 3:00:00 AM

FDA Approves Vemurafenib for Treating Erdheim-Chester Disease - Cancer Network
FDA Approves Vemurafenib for Treating Erdheim-Chester Disease  Cancer Network
Thursday, November 9, 2017 3:00:00 AM

Genes associated with Erdheim-Chester disease also linked to cancer: New drug treatments to be tested - Science Daily
Genes associated with Erdheim-Chester disease also linked to cancer: New drug treatments to be tested  Science Daily
Friday, March 31, 2017 3:00:00 AM

Glottic Cancer Treatment Market Huge Growth Opportunity by 2025 via These Industry Trends Report - Skyline Gazette
Glottic Cancer Treatment Market Huge Growth Opportunity by 2025 via These Industry Trends Report  Skyline Gazette
Monday, March 30, 2020 12:27:00 AM

The ultra-rare Erdheim-Chester disease: Turning grief into a campaign for a cure - Washington Post
The ultra-rare Erdheim-Chester disease: Turning grief into a campaign for a cure  Washington Post
Monday, November 17, 2014 3:00:00 AM

Share with Others

© Histiocytosis Association, Inc.
332 North Broadway, Pitman, New Jersey  08071 USA
Phone: +1 856-589-6606 | Fax: +1 856-589-6614
| info@histio.org
US & Canada Toll-Free: 1-800-548-2758 
Privacy | DisclaimerState Fundraising Notices 
Tax ID: 22-2827069 | Contact Us 
Follow Me on Pinterest   


¿No Habla Inglés? Si usted puede escribirme sus preguntas y preocupaciones a la dirección de correo electrónico: outreach@histio.org. Nosotros podremos responderle tan pronto nos sea possible. Gracias!